000 01427 a2200373 4500
001 1317020804
005 20250317111627.0
008 250312042016GB eng
020 _a9781317020806
037 _bTaylor & Francis
_cGBP 51.99
_fBB
040 _a01
041 _aeng
072 7 _aKCP
_2thema
072 7 _aKND
_2thema
072 7 _aLNTM
_2thema
072 7 _aJPS
_2thema
072 7 _a1KBB
_2bisac
072 7 _a1QFG
_2bisac
072 7 _aKCP
_2bic
072 7 _aKNDP
_2bic
072 7 _aLNTM
_2bic
072 7 _aJPS
_2bic
072 7 _a1KBB
_2bisac
072 7 _a1QFG
_2bisac
072 7 _aPOL023000
_2bisac
072 7 _aPOL000000
_2bisac
072 7 _a382.456151
_2bisac
100 1 _aSherry S. Marcellin
245 1 0 _aPolitical Economy of Pharmaceutical Patents
_bUS Sectional Interests and the African Group at the WTO
250 _a1
260 _aOxford
_bRoutledge
_c20160224
300 _a226 p
520 _bThis book provides a fresh, multidisciplinary, and exciting look at the making and remaking of pharmaceutical patents at the GATT/WTO, by utilising a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin focuses on the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement and consequently, the role of the African Group at the WTO in the remaking of those patent provisions.
999 _c6385
_d6385